Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
M-CSFR/CD115 Antibody (AFS98), Biotin, Novus Biologicals™

Rat Monoclonal Antibody
$390.00 - $878.00
Specifications
| Antigen | M-CSF R/CD115 |
|---|---|
| Clone | AFS98 |
| Concentration | 0.5 mg/mL |
| Dilution | Flow Cytometry 1:10-1:1000 |
| Applications | Flow Cytometry |
| Catalog Number | Mfr. No. | Quantity | Price | Quantity & Availability | |||||
|---|---|---|---|---|---|---|---|---|---|
| Catalog Number | Mfr. No. | Quantity | Price | Quantity & Availability | |||||
NBP14359205
![]() |
Novus Biologicals
NBP1435920.05MG |
0.05 mg |
Each for $390.00
|
|
|||||
NBP14359201
![]() |
Novus Biologicals
NBP1435920.1MG |
0.1 mg |
Each for $622.00
|
|
|||||
NBP1435925
![]() |
Novus Biologicals
NBP1435920.5MG |
0.5 mg |
Each for $878.00
|
|
|||||
Description
M-CSFR/CD115 Monoclonal specifically detects M-CSFR/CD115 in Mouse samples. It is validated for Flow Cytometry.Specifications
| M-CSF R/CD115 | |
| 0.5 mg/mL | |
| Flow Cytometry | |
| Biotin | |
| RUO | |
| Mouse | |
| P07333 | |
| 1436 | |
| The immunogen for this antibody was CD115. | |
| Primary | |
| Store at 4C. Do not freeze. |
| AFS98 | |
| Flow Cytometry 1:10-1:1000 | |
| Monoclonal | |
| Rat | |
| Protein Kinase | |
| Aqueous buffer, may contain carrier protein/stabilizer (proprietary) with 0.09% Sodium Azide | |
| CD115, CD115 antigen, C-FMS, colony stimulating factor 1 receptor, CSF-1-R, CSFR, EC 2.7.10.1, FMS proto-oncogene, FMSFIM2, macrophage colony stimulating factor I receptor, macrophage colony-stimulating factor 1 receptor, McDonough feline sarcoma viral (v-fms) oncogene homolog, Proto-oncogene c-Fms | |
| CSF1R | |
| IgG2a κ | |
| Affinity Purified |
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title